News and Upcoming events - Providence

Upcoming Events


Providence Medical Technology Secures $3 Million Venture Debt Funding

Providence Medical Technology, Inc. announced today it has closed a $3 million venture debt agreement with East West Bank. The debt facility complements the $6.8 million venture funding that closed earlier in 2014.

Providence Medical Technology Closes Series C Financing

Providence Medical Technology, Inc. today announced that it has closed a $6.8 million Series C round of financing. Stanmore Medical Investments led the round through its MedVest Fund One, and was joined by Aphelion Capital and RCT Ventures.

Providence Medical Technology Announces Availability of Two-Year Data on DTRAX Expandable Cage System (formerly marketed as DTRAX Facet System)

Providence Medical Technology, Inc. (PMT) today announced that two‐year follow‐up data on patients treated with the DTRAX Facet System will be available in the electronic poster session at the Congress of Neurological Surgeons (CNS) Annual Meeting in San Francisco, October 19‐23. This data represents follow‐up to the one‐year results published earlier in 2013 in the Journal of Neurosurgery: Spine.

Providence Medical Technology Awarded Five More Patents for Facet Joint Implants and Methods of Placement

Providence Medical Technology, Inc. (PMT) today announced that five U.S. patents have been issued in the past 12 months protecting the DTRAX® family of technologies, bringing the total number of U.S. patents issued to the company by the U.S. Patent Office to seven.

Team | Innovation | Quality | Passion | Transparency
Copyright © 2023, Providence Medical Technology. All rights reserved.